However, Minami et al. found that LIPI was an independent prognostic factor for cytotoxic chemotherapy in non-driver-driven NSCLC and EGFR-targeted therapy in EGFR-mutant NSCLC [96]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.